Assyro AI

Orange Book product · Brand (NDA)

SUPRENZA

PHENTERMINE HYDROCHLORIDE

Brand (NDA)NDA 202088DISCN CITIUS PHARMS

At a glance

Jun 13, 2011

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jun 13, 2011

    15 yr 3 mo ago

  2. Today

  3. Patent 8440170 expires

    Listed drug product patent expiration.

    Mar 14, 2029

    in 2 yr 9 mo

Pharmaceutical detail

Active ingredient

PHENTERMINE HYDROCHLORIDE

Strength

15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Dosage form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

TE code

Not listed

Application

NDA 202088

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

This is a brand (NDA) product. Other products sharing this active ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8440170Mar 14, 2029in 2 yr 9 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.